Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab

NCT00319839 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Head and Neck Cancer

Interventions

DRUG: Abraxane
DRUG: Cetuximab

Sponsor

University of California, Irvine